Completed PHASE4 INTERVENTIONAL 4-arm NCT02200822

Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients (STOP-CRT)

Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding Patients to Cardiac Resynchronization Therapy: the STOP-CRT Trial

Sponsor: Hasselt University

Conditions Heart Failure (HF)

Interventions RAAS blockers beta blockers

Updated 6 times since 2017 Last updated: Jul 30, 2019 Started: Jul 31, 2014 Primary completion: Feb 28, 2019 Completion: Feb 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Heart Failure (HF), this trial is completed. The trial is conducted by Hasselt University and has accumulated 6 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Sep 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Aug 2017 — Sep 2019 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Aug 2017 [monthly]

Recruiting PHASE4

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hasselt University
Ziekenhuis Oost-Limburg

Data source: Hasselt University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Genk, Belgium